Skip to content

News Category: Health & Medical

Nippon Express (Belgium) Acquires GDP Certification for Facility in Brussels Airport’s Cargo Area

By asianet

Nippon Express (Belgium) N.V./S.A. (hereinafter “NX Belgium”), a company of the Nippon Express Holdings, Inc. Group, has obtained Good Distribution Practice (GDP) certification, effective December 21, 2021, for air and ground forwarding operations, inclusive of inventory control, at a facility in the cargo area of Brussels Airport, evidencing its compliance with GDP standards for the … Continued

Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

By asianet

Nuvaxovid(TM) is the first protein-based COVID-19 vaccine to receive approval for provisional registration in Australia Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Australia’s Therapeutic Goods Administration (TGA) has granted approval for provisional registration of NVX-CoV2373, Novavax’ COVID-19 vaccine (adjuvanted), for active … Continued

GORE(R) CARDIOFORM Septal Occluder Marks 10 Years of Improving Lives

By asianet

— After a decade of clinical use* and more than 50,000 devices sold globally, the GORE(R) CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. W. L. Gore & Associates (Gore) today announced that the GORE(R) CARDIOFORM Septal Occluder has achieved 10 years of clinical use, treating patients through clinical studies and commercially … Continued

Octapharma puts a spotlight on the challenges of managing inhibitors in haemophilia A at the 15th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

By asianet

The virtual symposium held on Wednesday, February 2, 2022, at 18:00 CET, will tell the story of the Rodriguez family and their two sons with haemophilia A as they navigate the challenges of inhibitor management. Logo – https://mma.prnewswire.com/media/1727966/Octapharma_logo.jpg The development of inhibitors to replacement factor VIII (FVIII) therapy continues to be a significant concern for … Continued

Accomplished Pharma R&D leader, Sauri Gudlavalleti joins Sai Life Sciences as Chief Operating Officer

By asianet

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=sauri-gudlavalleti-joins-sai-life-sciences-as-coo] (CRO-CDMO), today announced the appointment of Sauri Gudlavalleti as its Chief Operating Officer. Sauri will report to the CEO & Managing Director, Krishna Kanumuri and drive the company’s growth as a new generation, science-driven organization. Making the announcement, Krishna Kanumuri said, … Continued

XtalPi Partners with Excelra for GOSTAR to Enhance its Intelligent Digital Drug Discovery and Development platform

By asianet

Excelra, a leading global Data & Analytics organization, today announced the partnership for its Global Online Structure Activity Relationship Database (GOSTAR) with XtalPi Inc., an AI-based pharmaceutical biotechnology company reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development platform. Excelra will provide ADMET datasets in the GOSTAR … Continued

CliniSys acquires HORIZON Lab Systems and combines with Sunquest Information Systems to create one of the world’s largest organizations dedicated to diagnostics and laboratory informatics

By asianet

– Combined group to enable better public health outcomes through innovation in diagnostics and laboratory informatics technology CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s largest organizations dedicated to diagnostic and laboratory informatics. CliniSys’ … Continued

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials

By asianet

– Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq – Spin-off to unlock value in the space of medical dermatology by using Novaliq’s transformative technology outside eye care – 3E Bioventures Capital and Beijing Whale Technology Corporation Ltd join as new investors – Proceeds will be used for three Phase 1/2a … Continued

Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant

By asianet

The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR detection kits capable of identifying putative Omicron variant infections, directly at the moment of the positivity test. To support this recommendation, Menarini offers CoronaMeltVAR, a CE-IVD Real-Time PCR … Continued

MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker

By asianet

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea. The devices are equipped with Bluetooth technology for streamlined remote monitoring when paired with MicroPort CRM’s SmartView Connect home monitor, already approved in Japan. Alizea … Continued